Compounds > ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate
Page last updated: 2024-08-23

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cardiovascular Stroke

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bush, LR; Cavallo, GC; Heathers, GP; Higgins, AJ; Hirkaler, GM; Kozak, MZ; Vogel, WM1

Other Studies

1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cardiovascular Stroke

ArticleYear
Inhibition of long-chain acylcarnitine accumulation during coronary artery occlusion does not alter infarct size in dogs.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5

    Topics: Acetylcarnitine; Analysis of Variance; Animals; Blood Pressure; Carnitine Acyltransferases; Dogs; Epoxy Compounds; Female; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion

1994